An Observational Study of Patients Living With Chronic Neurological Diseases

NCT05796037 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500000

Last updated 2024-11-20

No results posted yet for this study

Summary

TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).

Conditions

Sponsors & Collaborators

  • Target PharmaSolutions, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2038-12-31
Completion
2038-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05796037 on ClinicalTrials.gov